XNCR Q1 2025 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$33M+104.6% YoY

Gross Profit

$30M91.8% margin

Operating Income

-$43M-131.9% margin

Net Income

-$48M-147.9% margin

EPS (Diluted)

$-0.66

QoQ Revenue Growth

-53.3%

Cash Flow

Operating Cash Flow

-$16M

Free Cash Flow

-$18M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$905M

Total Liabilities

$265M

Stockholders' Equity

$640M

Cash & Equivalents

$40M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$16M	+104.6%
Gross Profit	$30M	$16M	+87.8%
Operating Income	-$43M	-$55M	+21.0%
Net Income	-$48M	-$73M	+34.1%

Revenue Segments

Royalty

$18M56%

Milestone

$15M44%